TNF-α is critical to facilitate hemopoietic stem cell engraftment and function

Journal of Immunology

Volumn 180, Issue 1, 2008, Pages 49-57

  Rezzoug, Francine ^a   Huang, Yiming ^a   Tanner, Michael K ^a   Wysoczynski, Marcin ^a   Schanie, Carrie L ^a   Chilton, Paula M ^a   Ratajczak, Mariusz Z ^a   Fugier Vivier, Isabelle J ^a   Ildstad, Suzanne T ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 3; TUMOR NECROSIS FACTOR ALPHA; CD8 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; ONCOPROTEIN; PROTO ONCOGENE PROTEIN BCL 3; PROTO-ONCOGENE PROTEIN BCL-3; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL INTERACTION; CHIMERA; CLONOGENESIS; CONTROLLED STUDY; ENGRAFTMENT; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ANIMAL; C57BL MOUSE; CYTOLOGY; DENDRITIC CELL; DRUG ANTAGONISM; GENETICS; HISTOCOMPATIBILITY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD8; APOPTOSIS; DENDRITIC CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TRANSCRIPTION FACTORS; TRANSPLANTATION IMMUNOLOGY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40449113243     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.1.49     Document Type: Article

References (47)

1. Lu, L., R. N. Shen, and H. E. Broxmeyer. 1996. Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: current status and future application. Crit. Rev. Oncol. Hematol. 22: 61-78.
2. Korbling, M., and P. Anderlini. 2001. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood 98: 2900-2908.
3. Kaufman, C. L., Y. L. Colson, S. M. Wren, S. L. Watkins, R. L. Simmons, and S. T. Ildstad. 1994. Phenotypic characterization of a novel bone-marrow derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84: 2436-2446.
4. Grimes, H. L., C. L. Schanie, Y. Huang, D. Cramer, F. Rezzoug, I. Fugier-Vivier, and S. T. Ildstad. 2004. Graft facilitating cells are derived from hematopoietic stem cells and functionally require CD3, but are distinct from T lymphocytes. Exp. Hematol. 32: 946-954.
5. Fugier-Vivier, I., F. Rezzoug, Y. Huang, A. J. Graul-Layman, C. L. Schanie, H. Xu, P. M. Chilton, and S. T. Ildstad. 2005. Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J. Exp. Med. 201: 373-383.
6. Huang, Y., F. Rezzoug, P. M. Chilton, H. L. Grimes, D. E. Cramer, and S. T. Ildstad. 2004. Matching at the MHC class I K locus is essential for long-term engraftment of purified hematopoietic stem cells: a role for host NK cells in regulating HSC engraftment. Blood 104: 873-880.
7. Eaves, C. J., J. D. Cashman, R. J. Kay, G. J. Dougherty, T. Otsuka, L. A. Gaboury, D. E. Hogge, P. M. Lansdorp, A. C. Eaves, and R. K. Humphries. 1991. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78: 110-117.
8. Calvi, L. M., G. B. Adams, K. W. Weibrecht, J. M. Weber, D. P. Olson, M. C. Knight, R. P. Martin, E. Schipani, P. Divieti, F. R. Bringhurst, et al. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425: 841-846.
9. + cells: evidence for an autocrine/paracrine mechanism. Blood 99: 1117-1129.
10. Karlsson, R., M. Engstrom, M. Jonsson, P. Karlberg, C. J. Pronk, J. Richter, and J. I. Jonsson. 2003. Phosphatidylinositol 3-kinase is essential for kit ligand-mediated survival, whereas interleukin-3 and flt3 ligand induce expression of antiapoptotic Bcl-2 family genes. J. Leukocyte Biol. 74: 923-931.
11. Broxmeyer, H. E., S. Cooper, L. Kohli, G. Hangoc, Y. Lee, C. Mantel, D. W. Clapp, and C. H. Kim. 2003. Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/ antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo. J. Immunol. 170: 421-429.
12. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 91: 4523-4530.
13. Wright, D. E., E. P. Bowman, A. J. Wagers, E. C. Butcher, and I. L. Weissman. 2002. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J. Exp. Med. 195: 1145-1154.
14. Matsunaga, T., T. Kato, H. Miyazaki, and M. Ogawa. 1998. Thrombopoietin promotes the survival of murine hematopoietic long-term reconstituting cells: comparison with the effects of FLT3/FLK-2 ligand and interleukin-6. Blood 92: 452-461.
15. Wineman, J. P., S. Nishikawa, and C. E. Muller-Sieburg. 1993. Maintenance of high levels of pluripotent hematopoietic stem cells in vitro: effect of stromal cells and c-kit. Blood 81: 365-372.
16. Caux, C., C. Favre, S. Saeland, V. Duvert, I. Durand, P. Mannoni, and J. Banchereau. 1991. Potentiation of early hematopoiesis by tumor necrosis factor-α is followed by inhibition of granulopoietic differentiation and proliferation. Blood 78: 635-644.
17. Snoeck, H. W., S. Weekx, A. Moulijn, F. Lardon, M. Lenjou, G. Nys, P. C. Van Ranst, D. R. Van Bockstaele, and Z. N. Berneman. 1996. Tumor necrosis factor α is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor α but not to interferon γ. J. Exp. Med. 183: 705-710.
18. Jacobsen, S. E., F. W. Ruscetti, C. M. Dubois, and J. R. Keller. 1992. Tumor necrosis factor α directly and indirectly regulates hematopoietic progenitor cell proliferation: role of colony-stimulating factor receptor modulation. J. Exp. Med. 175: 1759-1772.
19. Rusten, L. S., F. W. Jacobsen, W. Lesslauer, H. Loetscher, E. B. Smeland, and S. E. Jacobsen. 1994. Bifunctional effects of tumor necrosis factor α (TNF α) on the growth of mature and primitive human hematopoietic progenitor cells: involvement of p55 and p75 TNF receptors. Blood 83: 3152-3159.
20. Ploemacher, R. E., J. P. van der Sluijs, J. A. Voerman, and N. C. Brons. 1989. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 74: 2755-2763.
21. cip1/waf1. Science 287: 1804-1808.
22. de Haan, G., S. J. Szilvassy, T. E. Meyerrose, B. Dontje, B. Grimes, and G. Van Zant. 2000. Distinct functional properties of highly purified hematopoietic stem cells from mouse strains differing in stem cell numbers. Blood 96: 1374-1379.
23. + early erythroid progenitors are resistant to several erythropoietic "inhibitory" cytokines: role of FLIP. Br. J. Haematol. 123: 160-169.
24. Domen, J., S. H. Cheshier, and I. L. Weissman. 2000. The role of apoptosis in the regulation of hematopoietic stem cells: overexpression of Bcl-2 increases both their number and repopulation potential. J. Exp. Med. 191: 253-264.
25. Liu, B., S. M. Buckley, I. D. Lewis, A. I. Goldman, J. E. Wagner, and J. C. van der Loo. 2003. Homing defect of cultured human hematopoietic cells in the NOD/SCID mouse is mediated by Fas/CD95. Exp. Hematol. 31: 824-832.
26. L expression in stem cells facilitates engraftment and reduces the need for host conditioning during bone marrow transplantation. Am. J. Transplant. 4: 58-64.
27. Brawand, P., D. R. Fitzpatrick, B. W. Greenfield, K. Brasel, C. R. Maliszewski, and T. De Smedt. 2002. Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J. Immunol. 169: 6711-6719.
28. Yaroslavskiy, B., Y. L. Colson, S. T. Ildstad, D. Parrish, and S. S. Boggs. 1998. Addition of a bone marrow "facilitating cell" population increases stem cell-derived cobblestone area formation in impaired long-term bone marrow culture stroma. Exp. Hematol. 26: 604-611.
29. Zhang, Y., A. Harada, H. Bluethmann, J. B. Wang, S. Nakao, N. Mukaida, and K. Matsushima. 1995. Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF α in vitro. Blood 86: 2930-2937.
30. Broxmeyer, H. E., D. E. Williams, L. Lu, S. Cooper, S. L. Anderson, G. S. Beyer, R. Hoffman, and B. Y. Rubin. 1986. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-γ. J. Immunol. 136: 4487-4495.
31. Maguer-Satta, V., R. Oostendorp, D. Reid, and C. J. Eaves. 2000. Evidence that ceramide mediates the ability of tumor necrosis factor to modulate primitive human hematopoietic cell fates. Blood 96: 4118-4123.
32. Szilvassy, S. J., T. E. Meyerrose, and B. Grimes. 2000. Effects of cell cycle activation on the short-term engraftment properties of ex vivo expanded murine hematopoietic cells. Blood 95: 2829-2837.
33. + cells in non-obese diabetic/severe combined immune-deficient mice. Blood 92: 2641-2649.
34. Peters, R., S. Leyvraz, and L. Perey. 1998. Apoptotic regulation in primitive hematopoietic precursors. Blood 92: 2041-2052.
35. Ogilvy, S., D. Metcalf, C. G. Print, M. L. Bath, A. W. Harris, and J. M. Adams. 1999. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc. Natl. Acad. Sci. USA 96: 14943-14948.
36. Park, J. R., I. D. Bernstein, and D. M. Hockenbery. 1995. Primitive human hematopoietic precursors express Bcl-x but not Bcl-2. Blood 86: 868-876.
37. + hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis. Stem Cells 20: 174-182.
38. Bours, V., G. Franzoso, V. Azarenko, S. Park, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 72: 729-739.
39. Cogswell, P. C., D. C. Guttridge, W. K. Funkhouser, and A. S. Baldwin, Jr. 2000. Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3. Oncogene 19: 1123-1131.
40. Mitchell, T. C., D. Hildeman, R. M. Kedl, T. K. Teague, B. C. Schaefer, J. White, Y. Zhu, J. Kappler, and P. Marrack. 2001. Immunological adjuvants promote activated T cell survival via induction of Bcl-3. Nat. Immunol. 2: 397-402.
41. Zhang, M. Y., E. W. Harhaj, L. Bell, S. C. Sun, and B. A. Miller. 1998. Bcl-3 expression and nuclear translocation are induced by granulocyte-macrophage colony-stimulating factor and erythropoietin in proliferating human erythroid precursors. Blood 92: 1225-1234.
42. L, costimulation, or antioxidants with adjuvant-induced T cell survival. Ann. NY Acad. Sci. 975: 114-131.
43. Dempsey, P. W., S. E. Doyle, J. Q. He, and G. Cheng. 2003. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 14: 193-209.
44. Bryder, D., V. Ramsfjell, I. Dybedal, K. Theilgaard-Monch, C. M. Hogerkorp, J. Adolfsson, O. J. Borge, and S. E. Jacobsen. 2001. Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation. J. Exp. Med. 194: 941-952.
45. Kerzic, P. J., D. W. Pyatt, J. H. Zheng, S. A. Gross, A. Le, and R. D. Irons. 2003. Inhibition of NF-κB by hydroquinone sensitizes human bone marrow progenitor cells to TNF-α-induced apoptosis. Toxicology 187: 127-137.
46. + bone marrow cell survival. Blood 93: 3302-3308.
47. Brasier, A. R., M. Lu, T. Hai, Y. Lu, and I. Boldogh. 2001. NF-κB-inducible BCL-3 expression is an autoregulatory loop controlling nuclear p50/NF-κB1 residence. J. Biol. Chem. 276: 32080-32093.